Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: OCL015
MIFTS: 39

Oculomotor Apraxia

Categories: Eye diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Oculomotor Apraxia

About this section

MalaCards integrated aliases for Oculomotor Apraxia:

Name: Oculomotor Apraxia 58 29 6

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases
See all MalaCards categories (disease lists)
Orphanet: 58  
Rare eye diseases


External Ids:

Orphanet 58 ORPHA98688
Sources

Summaries for Oculomotor Apraxia

About this section
MalaCards based summary : Oculomotor Apraxia is related to spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 and ataxia-oculomotor apraxia 3, and has symptoms including ophthalmoparesis An important gene associated with Oculomotor Apraxia is ATM (ATM Serine/Threonine Kinase), and among its related pathways/superpathways are DNA Double-Strand Break Repair and Chks in Checkpoint Regulation. The drugs Ethanol and Coenzyme Q10 have been mentioned in the context of this disorder. Affiliated tissues include eye, bone marrow and pineal, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Wikipedia : 74 Oculomotor apraxia (OMA), is the absence or defect of controlled, voluntary, and purposeful eye... more...

Sources

Related Diseases for Oculomotor Apraxia

About this section

Diseases related to Oculomotor Apraxia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 147)
# Related Disease Score Top Affiliating Genes
1 spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 33.2 SETX PIK3R5 APTX
2 ataxia-oculomotor apraxia 3 33.1 SETX PIK3R5 APTX
3 ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia 32.4 XRCC1 SETX PNKP MRE11 ATM APTX
4 joubert syndrome 2 32.3 NPHP1 AHI1
5 joubert syndrome 25 32.3 CSPP1 CEP104
6 joubert syndrome 6 32.1 NPHP1 AHI1
7 joubert syndrome 21 32.1 CSPP1 CEP104
8 joubert syndrome 10 31.9 NPHP1 AHI1
9 joubert syndrome 24 31.9 NPHP1 AHI1
10 joubert syndrome 26 31.9 CSPP1 CEP104
11 joubert syndrome 13 31.9 NPHP1 AHI1
12 joubert syndrome 8 31.8 NPHP1 AHI1
13 joubert syndrome 7 31.8 NPHP1 AHI1
14 joubert syndrome 5 31.8 NPHP1 AHI1
15 joubert syndrome 4 31.6 NPHP1 AHI1
16 ataxia-telangiectasia 31.6 XRCC1 MRE11 ATM APTX
17 ocular motor apraxia 31.5 NPHP1 HARS1 DHX30 COMA ATM APTX
18 autosomal recessive cerebellar ataxia 31.0 SETX ATM APTX
19 cogan syndrome 30.7 NPHP1 AHI1
20 vitamin e, familial isolated deficiency of 30.3 SETX APTX
21 hereditary ataxia 30.3 SETX PNKP ATM APTX
22 autosomal dominant cerebellar ataxia 30.0 SETX PNKP APTX
23 apraxia 29.9 XRCC4 XRCC1 SETX PNKP PIK3R5 NPHP1
24 microcephaly 28.5 XRCC4 PNKP MRE11 HARS1 DHX30 ATM
25 ataxia-oculomotor apraxia 4 11.9
26 wieacker-wolff syndrome 11.5
27 birk-landau-perez syndrome 11.4
28 joubert syndrome 16 11.3
29 joubert syndrome 15 11.2
30 spastic ataxia 5, autosomal recessive 11.2
31 joubert syndrome 35 11.2
32 poretti-boltshauser syndrome 11.2
33 autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome 11.2
34 joubert syndrome 1 11.1
35 ataxia-telangiectasia-like disorder 1 11.1
36 acrocallosal syndrome 11.1
37 anemia, sideroblastic, and spinocerebellar ataxia 11.1
38 joubert syndrome 3 11.1
39 joubert syndrome 9 11.1
40 nephronophthisis 12 11.1
41 spinocerebellar ataxia 36 11.1
42 meckel syndrome, type 10 11.1
43 joubert syndrome 17 11.1
44 joubert syndrome 18 11.1
45 nephronophthisis 14 11.1
46 joubert syndrome 20 11.1
47 joubert syndrome 22 11.1
48 joubert syndrome 23 11.1
49 joubert syndrome 27 11.1
50 joubert syndrome 28 11.1

Graphical network of the top 20 diseases related to Oculomotor Apraxia:



Diseases related to Oculomotor Apraxia
Sources

Symptoms & Phenotypes for Oculomotor Apraxia

About this section

UMLS symptoms related to Oculomotor Apraxia:


ophthalmoparesis

GenomeRNAi Phenotypes related to Oculomotor Apraxia according to GeneCards Suite gene sharing:

26 (show all 20)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-124 9.91 PIK3R5
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-144 9.91 DHX30
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-148 9.91 PIK3R5
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-16 9.91 ATM DHX30
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-169 9.91 PIK3R5
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-175 9.91 HARS1
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-177 9.91 DHX30
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-206 9.91 DHX30
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-214 9.91 ATM
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-215 9.91 ATM
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-216 9.91 DHX30
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-29 9.91 HARS1
13 Decreased shRNA abundance (Z-score < -2) GR00366-A-40 9.91 HARS1
14 Decreased shRNA abundance (Z-score < -2) GR00366-A-50 9.91 PIK3R5
15 Decreased shRNA abundance (Z-score < -2) GR00366-A-53 9.91 DHX30
16 Decreased shRNA abundance (Z-score < -2) GR00366-A-54 9.91 HARS1
17 Decreased shRNA abundance (Z-score < -2) GR00366-A-81 9.91 ATM
18 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.44 MRE11 SETX XRCC1
19 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.44 ATM MRE11 SETX XRCC1
20 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-3 9.44 ATM MRE11 PNKP SETX XRCC1 XRCC4

MGI Mouse Phenotypes related to Oculomotor Apraxia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.32 AHI1 APTX ATM MRE11 NPHP1 PIK3R5
Sources

Drugs & Therapeutics for Oculomotor Apraxia

About this section

Drugs for Oculomotor Apraxia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 9)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 3 64-17-5 702
2
Coenzyme Q10 Approved, Investigational, Nutraceutical Phase 3 303-98-0 5281915
3
Lecithin Experimental Phase 3 8002-43-5
4 Trace Elements Phase 3
5 Complement System Proteins Phase 3
6 Vitamins Phase 3
7 Ubiquinone Phase 3
8 Nutrients Phase 3
9 Micronutrients Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 Completed NCT02333305 Phase 3

Search NIH Clinical Center for Oculomotor Apraxia

Sources

Genetic Tests for Oculomotor Apraxia

About this section

Genetic tests related to Oculomotor Apraxia:

# Genetic test Affiliating Genes
1 Oculomotor Apraxia 29
Sources

Anatomical Context for Oculomotor Apraxia

About this section

MalaCards organs/tissues related to Oculomotor Apraxia:

40
Eye, Bone Marrow, Pineal
Sources

Publications for Oculomotor Apraxia

About this section

Articles related to Oculomotor Apraxia:

(show top 50) (show all 395)
# Title Authors PMID Year
1
Some pathogenic SETX variants are partially conserved during evolution. 61
33333218 2021
2
A novel mutation in ATM gene in a Saudi female with ataxia telangiectasia. 61
32172615 2021
3
Premature ovarian ageing following heterozygous loss of Senataxin. 61
33337500 2021
4
Who is really blind in the time of coronavirus: the patient or the doctor? A rare case of Balint's syndrome. 61
33400067 2021
5
Clinical and radiological features of posterior cortical atrophy (PCA) in a GRN mutation carrier: a case report. 61
33030763 2021
6
Asymmetric Bálint's syndrome with multimodal agnosia, bilateral agraphesthesia, and ineffective kinesthetic reading due to subcortical hemorrhage in the left parieto-occipito-temporal area. 61
33103577 2020
7
Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation. 61
33080427 2020
8
Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker. 61
33044027 2020
9
The Phenotypic Spectrum of PNKP-Associated Disease and the Absence of Immunodeficiency and Cancer Predisposition in a Dutch Cohort. 61
32980744 2020
10
Generation and characterization of induced pluripotent stem cell (iPSC) line (JUCTCi002-A) from a patient with ataxia with oculomotor apraxia type 1 (AOA1) harboring a homozygous mutation in the APTX gene. 61
32769066 2020
11
Complex Movement Disorders in Ataxia with Oculomotor Apraxia Type 1: Beyond the Cerebellar Syndrome. 61
33101765 2020
12
Teaching Video NeuroImages: Posterior cortical atrophy presenting with Balint's syndrome. 61
32928969 2020
13
SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy regulation. 61
32686621 2020
14
An Atypical Presentation of Joubert Syndrome Due to a Novel Mutation in ZNF423 Gene. 61
33531950 2020
15
Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair. 61
32504494 2020
16
Tight expression regulation of senataxin, linked to motor neuron disease and ataxia, is required to avert cell-cycle block and nucleolus disassembly. 61
32577562 2020
17
Clinical and Molecular Diagnosis of Joubert Syndrome and Related Disorders. 61
32139166 2020
18
Expanding the clinical and neuroimaging features of NKX6-2-related hereditary spastic ataxia type 8. 61
32004679 2020
19
Novel MAG Variant Causes Cerebellar Ataxia with Oculomotor Apraxia: Molecular Basis and Expanded Clinical Phenotype. 61
32340215 2020
20
Clinical Features and Molecular Genetics of Autosomal Recessive Ataxia in the Turkish Population. 61
33042236 2020
21
Atypical, milder presentation in a child with CC2D2A and KIDINS220 variants. 61
31577543 2020
22
Identification of APTX disease-causing mutation in two unrelated Jordanian families with cerebellar ataxia and sensitivity to DNA damaging agents. 61
32750061 2020
23
Genetic and phenotypic features of patients with childhood ataxias diagnosed by next-generation sequencing gene panel. 61
31493945 2020
24
Novel compound heterozygous TMEM67 variants in a Vietnamese family with Joubert syndrome: a case report. 61
32000717 2020
25
Linker region is required for efficient nuclear localization of polynucleotide kinase phosphatase. 61
32970693 2020
26
Clinical Presentation of Ataxia-Telangiectasia. 61
31823618 2019
27
From congenital microcephaly to adult onset cerebellar ataxia: Distinct and overlapping phenotypes in patients with PNKP gene mutations. 61
31436889 2019
28
A novel PDE6D mutation in a patient with Joubert syndrome type 22 (JBTS22). 61
30423442 2019
29
Compound Heterozygous Mutations in PNKP Gene in an Iranian Child with Microcephaly, Seizures, and Developmental Delay. 61
31707899 2019
30
Genetic study in a family with dopa-responsive dystonia revealed a novel mutation in sepiapterin reductase gene. 61
31777525 2019
31
A Preventable Ataxia: Cerebrotendinous Xanthomatosis. 61
31736580 2019
32
Teaching Video NeuroImages: Characteristic head jerks in congenital oculomotor apraxia due to Joubert syndrome. 61
31501314 2019
33
The molecular genetics of Joubert syndrome and related ciliopathies: The challenges of genetic and phenotypic heterogeneity. 61
31763177 2019
34
PNKP deficiency mimicking a benign hereditary chorea: The misleading presentation of a neurodegenerative disorder. 61
30956058 2019
35
Gaucher disease type 3c: New patients with unique presentations and review of the literature. 61
31130326 2019
36
Germ cell arrest associated with aSETX mutation in ataxia oculomotor apraxia type 2. 61
30642639 2019
37
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2). 61
30778901 2019
38
Ataxia with Oculomotor Apraxia Type 4 with PNKP Common "Portuguese" and Novel Mutations in Two Belarusian Families. 61
31061747 2019
39
Hereditary Ataxia with a Novel Mutation in the Senataxin Gene: A Case Report. 61
31182894 2019
40
Diminished OPA1 expression and impaired mitochondrial morphology and homeostasis in Aprataxin-deficient cells. 61
30986824 2019
41
Bi-allelic Mutations in FAM149B1 Cause Abnormal Primary Cilium and a Range of Ciliopathy Phenotypes in Humans. 61
30905400 2019
42
A case series of hereditary cerebellar ataxias in a highly consanguineous population from Northeast Brazil. 61
30389370 2019
43
Genetic analysis of undiagnosed ataxia-telangiectasia-like disorders. 61
30301590 2019
44
[Diagnostic algorithm for autosomal recessive ataxia]. 61
31626222 2019
45
Progressive Ataxia with Elevated Alpha-Fetoprotein: Diagnostic Issues and Review of the Literature. 61
31656689 2019
46
A Novel Homozygous Variant in the Fork-Head-Associated Domain of Polynucleotide Kinase Phosphatase in a Patient Affected by Late-Onset Ataxia With Oculomotor Apraxia Type 4. 61
32010037 2019
47
A new MRI marker of ataxia with oculomotor apraxia. 61
30599859 2019
48
Ataxia-telangiectasia-like disorder in a family deficient for MRE11A, caused by a MRE11 variant. 61
30584599 2018
49
[Ataxia telangiectasia. A prototype of neurological involvement in primary immune deficiencies]. 61
30525879 2018
50
Joubert Syndrome: Ophthalmological Findings in Correlation with Genotype and Hepatorenal Disease in 99 Patients Prospectively Evaluated at a Single Center. 61
30055837 2018
Sources

Variations for Oculomotor Apraxia

About this section

ClinVar genetic disease variations for Oculomotor Apraxia:

6
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 ATM NM_000051.3(ATM):c.689del (p.Asn230fs) Deletion Pathogenic 374194 rs1057518965 11:108115539-108115539 11:108244812-108244812
2 DHX30 NM_138615.3(DHX30):c.1478G>A (p.Arg493His) SNV Pathogenic 375374 rs1057519436 3:47888040-47888040 3:47846550-47846550
3 HARS1 NM_002109.6(HARS1):c.616G>T (p.Asp206Tyr) SNV Pathogenic 804285 rs1131040 5:140057507-140057507 5:140677922-140677922
4 HARS1 NM_002109.6(HARS1):c.730delG Deletion Pathogenic 804286 rs1581505917 5:140057005-140057005 5:140677420-140677420
5 HERC2 NM_004667.5(HERC2):c.5045A>G (p.Asn1682Ser) SNV Uncertain significance 599009 rs140073033 15:28474681-28474681 15:28229535-28229535
6 RYR1 NM_000540.2(RYR1):c.1312G>C (p.Glu438Gln) SNV Uncertain significance 599010 rs765668209 19:38943526-38943526 19:38452886-38452886
7 TGM6 NM_198994.3(TGM6):c.76C>T (p.Pro26Ser) SNV Uncertain significance 523569 rs766248910 20:2375166-2375166 20:2394520-2394520
8 AHI1 NM_001134831.2(AHI1):c.2299G>T (p.Val767Leu) SNV Uncertain significance 260843 rs755688765 6:135752420-135752420 6:135431282-135431282
9 ARFGEF1 NM_024790.6(CSPP1):c.3281A>G (p.Glu1094Gly) SNV Uncertain significance 510229 rs201629827 8:68102960-68102960 8:67190725-67190725
10 TCF4 NM_001083962.2(TCF4):c.1106C>A (p.Ala369Asp) SNV Likely benign 983479 rs1016959427 18:52924586-52924586 18:55257355-55257355
Sources

Expression for Oculomotor Apraxia

About this section
Search GEO for disease gene expression data for Oculomotor Apraxia.
Sources

Pathways for Oculomotor Apraxia

About this section

Pathways related to Oculomotor Apraxia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
DNA Double-Strand Break Repair 65
Show member pathways
 12.8 XRCC4 XRCC1 PNKP MRE11 ATM
2
Chks in Checkpoint Regulation 63
Show member pathways
 12.16 XRCC4 XRCC1 PNKP MRE11 ATM
3
DNA Damage 4
11.82 XRCC1 PNKP MRE11 ATM APTX
4
BARD1 signaling events 1
10.83 MRE11 ATM
5
Gemtuzumab ozogamicin Pathway, Pharmacokinetics/Pharmacodynamics 60
10.68 XRCC4 ATM
6
DDX1 as a regulatory component of the Drosha microprocessor 1
Show member pathways
 10.46 MRE11 ATM
7
DNA damage_NHEJ mechanisms of DSBs repair 23
10.18 XRCC4 PNKP MRE11
Sources

GO Terms for Oculomotor Apraxia

About this section

Cellular components related to Oculomotor Apraxia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chromosome, telomeric region GO:0000781 8.92 XRCC1 SETX MRE11 ATM

Biological processes related to Oculomotor Apraxia according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 nucleic acid phosphodiester bond hydrolysis GO:0090305 9.65 PNKP MRE11 APTX
2 DNA recombination GO:0006310 9.61 XRCC4 SETX MRE11
3 double-strand break repair via nonhomologous end joining GO:0006303 9.56 XRCC4 XRCC1 MRE11 ATM
4 double-strand break repair via homologous recombination GO:0000724 9.54 XRCC1 MRE11 ATM
5 positive regulation of telomere maintenance via telomerase GO:0032212 9.51 PNKP ATM
6 cellular response to DNA damage stimulus GO:0006974 9.5 XRCC4 XRCC1 SETX PNKP MRE11 ATM
7 reciprocal meiotic recombination GO:0007131 9.49 MRE11 ATM
8 DNA double-strand break processing GO:0000729 9.46 MRE11 ATM
9 double-strand break repair GO:0006302 9.46 XRCC4 SETX MRE11 APTX
10 single strand break repair GO:0000012 9.4 XRCC1 APTX
11 negative regulation of protein ADP-ribosylation GO:0010836 9.32 XRCC1 PNKP
12 DNA repair GO:0006281 9.17 XRCC4 XRCC1 SETX PNKP MRE11 ATM

Molecular functions related to Oculomotor Apraxia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.63 XRCC4 SETX MRE11 HARS1 ATM AHI1
2 double-stranded DNA binding GO:0003690 9.13 PNKP MRE11 APTX
3 damaged DNA binding GO:0003684 8.8 XRCC1 PNKP APTX
Sources

Sources for Oculomotor Apraxia

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....